2024 Annual Meeting | C137 - Low and High Pressure Headache: Clinical Presentation and Approach to Evaluation and Management

Date Tuesday 04/16/24

Time 03:30 PM - 05:30 PM MDT Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Kerry L. Knievel, DO

Topic(s) Headache

Learning Objectives Participants should be able to identify the signs and symptoms of low pressure headache, differentiating from other etiologies of orthostatic headache; provide an evaluation of CSF leak through imaging and conservative and interventional treatments and potential treatment complications; and learn about the clinical presentation, clinical and imaging findings of elevated CSF pressure, diagnostic and treatment options, and important aspects of management and patient monitoring.

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Medical Knowledge

Program Level Advanced

Program Tracks Neurohospitalist

Recommended Audience Fellow, Resident, General Neurologist, Specialist Neurologist, Advanced Practice Provider, Neurohospitalist

Teaching Styles Case-based, Didactic

Program Evaluations

Event Timeline
03:30 PM - 03:55 PM MDT	Speaker	Clinical Diagnosis and Management of Low CSF Pressure Kerry L. Knievel, DO
03:55 PM - 04:20 PM MDT	Speaker	Neuroradiology Diagnosis and Treatment of Spinal CSF leak Linda Gray-Leithe, MD
04:20 PM - 04:45 PM MDT	Speaker	Clinical Diagnosis and Management of High CSF Pressure Courtney Schusse, MD, FAAN
04:45 PM - 05:10 PM MDT	Speaker	Neuroradiology in High CSF Pressure: Venous Outflow Nick Befera
05:10 PM - 05:30 PM MDT	Q&A	Questions, Answers, and Discussion Kerry L. Knievel, DO

Faculty Disclosures
Kerry L. Knievel, DO	Dr. Knievel has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie . Dr. Knievel has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biohaven . Dr. Knievel has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck . Dr. Knievel has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lilly. Dr. Knievel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Pfizer. Dr. Knievel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck . Dr. Knievel has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for AbbVie . Dr. Knievel has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amgen . Dr. Knievel has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biohaven . Dr. Knievel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Lundbeck . Dr. Knievel has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Headache Cooperative of the Pacific . The institution of Dr. Knievel has received research support from Abbvie .
Courtney Schusse, MD, FAAN	Dr. Schusse has received personal compensation in the range of $500-$4,999 for serving as a Unaffiliated Neurotrauma Consultant with National Football League.
Nick Befera	No disclosure on file
Linda Gray-Leithe, MD	Dr. Gray-Leithe has nothing to disclose.

��ɫ��

��ɫ��